Business Description
Impel Pharmaceuticals Inc
NAICS : 541714
SIC : 2834
ISIN : US45258K1097
Description
IPI Legacy Liquidation Co formerly Impel Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases with high unmet medical needs, with an initial focus on diseases of the central nervous system. The company is developing an approach to drug delivery that administers specific formulations of drugs deep into the vascular-rich upper nasal space, a gateway for therapeutic administration of a versatile range of molecules and formulations.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | -2.62 | |||||
| Debt-to-Equity | -1.25 | |||||
| Debt-to-EBITDA | -1.67 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -23.55 | |||||
| Beneish M-Score | 20.89 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -4 | |||||
| 3-Year EPS without NRI Growth Rate | -12 | |||||
| 3-Year FCF Growth Rate | -11.9 | |||||
| 3-Year Book Growth Rate | 35.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 10.96 | |||||
| 9-Day RSI | 22.38 | |||||
| 14-Day RSI | 30.44 | |||||
| 6-1 Month Momentum % | -78.67 | |||||
| 12-1 Month Momentum % | -92 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.19 | |||||
| Quick Ratio | 0.13 | |||||
| Days Inventory | 285.4 | |||||
| Days Sales Outstanding | 115.62 | |||||
| Days Payable | 177.26 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -21.8 | |||||
| Shareholder Yield % | -6369.83 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 52.58 | |||||
| Operating Margin % | -334.06 | |||||
| Net Margin % | -353.93 | |||||
| FCF Margin % | -390.84 | |||||
| ROA % | -109.77 | |||||
| ROIC % | -116.11 | |||||
| ROC (Joel Greenblatt) % | -704.96 | |||||
| ROCE % | -1253.8 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.02 | |||||
| EV-to-EBIT | -1.64 | |||||
| EV-to-EBITDA | -1.67 | |||||
| EV-to-Revenue | 5.48 | |||||
| EV-to-FCF | -1.4 | |||||
| Earnings Yield (Greenblatt) % | -60.98 | |||||
| FCF Yield % | -22834.54 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Impel Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 19.595 | ||
| EPS (TTM) (€) | -2.931 | ||
| Beta | 0 | ||
| Volatility % | 198.72 | ||
| 14-Day RSI | 30.44 | ||
| 14-Day ATR (€) | 0.064025 | ||
| 20-Day SMA (€) | 0.387525 | ||
| 12-1 Month Momentum % | -92 | ||
| 52-Week Range (€) | 0.0405 - 3.82 | ||
| Shares Outstanding (Mil) | 23.9 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Impel Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Impel Pharmaceuticals Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Impel Pharmaceuticals Inc Frequently Asked Questions
What is Impel Pharmaceuticals Inc(FRA:84P)'s stock price today?
The current price of FRA:84P is €0.04. The 52 week high of FRA:84P is €3.82 and 52 week low is €0.04.
When is next earnings date of Impel Pharmaceuticals Inc(FRA:84P)?
The next earnings date of Impel Pharmaceuticals Inc(FRA:84P) is 2024-08-16 Est..
Does Impel Pharmaceuticals Inc(FRA:84P) pay dividends? If so, how much?
Impel Pharmaceuticals Inc(FRA:84P) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers